Vor Bio is dedicated to developing innovative therapeutics for autoimmune diseases, particularly through its lead candidate telitacicept, a dual BAFF/APRIL inhibitor. By targeting the root causes of these conditions, Vor Bio aims to transform how autoimmune care is approached and delivered.
No jobs found. Subscribe below to get notified when we find something for you.
Searching